US EditionPublished • loading... • Updated
Trump Jr.'s BlinkRx board seat draws Senate scrutiny as investigators probe pharma-linked telehealth prescribing
Summary by Drug Discovery and Development
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Trump Jr.'s BlinkRx board seat draws Senate scrutiny as investigators probe pharma-linked telehealth prescribing
As of early February, TrumpRx.gov displays only a stylized Oval Office portrait of the president and the words “Coming Soon.”In early 2025, Donald Trump Jr. joined the board of BlinkRx, a digital pharmacy company that later began marketing a service it says can stand up direct-to-consumer drug programs in as few as 21 days. Within… The post Trump Jr.’s BlinkRx board seat draws Senate scrutiny as investigators probe pharma-linked telehealth presc…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
